Notably, the FoxO1 inhibitor was toxic (> 70% cell killing) for BTK inhibitor–resistant primary CLL cells with BTK mutations cultured on plastic or in the coculture setting (P < 0.05; Figure 7, F and G, and Supplemental Figure 11B). Here, FOXO1 is linked to B-cell chronic lymphocytic leukemia.